Publications by authors named "Alexandra Bergk"

Claim this Profile
B
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C.
Viola Knop, Alexandra Bergk, Beate Schlosser, Juliane Thieringer, Florian van Bömmel

Eur J Gastroenterol Hepatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.
Viola Weich, Eva Herrmann, Tje Lin Chung, Christoph Sarrazin, Holger Hinrichsen, Alexandra Bergk

J Gastroenterol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
Andrej Potthoff, Heiner Wedemeyer, Wulf O Boecher, Thomas Berg, Stefan Zeuzem, Alexandra Bergk

J Hepatol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
Juliane Halangk, Christoph Sarrazin, Konrad Neumann, Gero Puhl, Tobias Mueller, Alexandra Bergk

J Hepatol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha.
Ursula Plöckinger, Denny Krüger, Alexandra Bergk, Viola Weich, Bertram Wiedenmann

Am J Gastroenterol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
Eckart Schott, Heiko Witt, Maria Pascu, Florian van Boemmel, Viola Weich, Alexandra Bergk

Eur J Gastroenterol Hepatol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
Eckart Schott, Heiko Witt, Konrad Neumann, Stefan Taube, Djin-Ye Oh, Alexandra Bergk

J Hepatol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.
Eckart Schott, Heiko Witt, Holger Hinrichsen, Konrad Neumann, Viola Weich, Alexandra Bergk

J Hepatol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.
Michael von Wagner, Miriam Huber, Thomas Berg, Holger Hinrichsen, Jens Rasenack, Alexandra Bergk

Gastroenterology· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection.
Florian van Bömmel, Thomas Wünsche, Stefan Mauss, Petra Reinke, Alexandra Bergk

Hepatology· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis